Evidence map›Paper›PMID 26022946›Full record

Observational studyThe European respiratory journal2015

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.

Helen L Barr, Nigel Halliday, Miguel Cámara, David A Barrett, Paul Williams, Douglas L Forrester, Rebecca Simms, Alan R Smyth, David Honeybourne, Joanna L Whitehouse and 5 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The European respiratory journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Metal-independent effects of calprotectin on cocultures ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Analysing theFrontiers in cellular and infection microbiology · 2025
    Review
  6. Article
  7. Article
  8. Heliyon · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Host and Bacterial Lipids inFrontiers in immunology · 2022
    Review
  16. Frontiers in microbiology · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Helen L BarrDivision of Respiratory Medicine, Clinical Sciences Building, University of Nottingham, City Hospital Campus, Nottingham, UK helen.barr@nottingham.ac.uk.
Nigel HallidaySchool of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
Miguel CámaraSchool of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
David A BarrettCentre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, UK.
Paul WilliamsSchool of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
Douglas L ForresterDivision of Respiratory Medicine, Clinical Sciences Building, University of Nottingham, City Hospital Campus, Nottingham, UK.
Rebecca SimmsDivision of Respiratory Medicine, Clinical Sciences Building, University of Nottingham, City Hospital Campus, Nottingham, UK.
Alan R SmythDivision of Child Health, Obstetrics and Gynaecology, University of Nottingham, University Hospital, Nottingham, UK.
David HoneybourneWest Midlands Adult CF Centre, Heart of England NHS Foundation Trust, Birmingham, UK.
Joanna L WhitehouseWest Midlands Adult CF Centre, Heart of England NHS Foundation Trust, Birmingham, UK.
Edward F NashWest Midlands Adult CF Centre, Heart of England NHS Foundation Trust, Birmingham, UK.
Jane DewarDept of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Andrew ClaytonDept of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Alan J KnoxDivision of Respiratory Medicine, Clinical Sciences Building, University of Nottingham, City Hospital Campus, Nottingham, UK.
Andrew W FogartyDivison of Epidemiology and Public Health, Clinical Sciences Building, University of Nottingham, Nottingham, UK.
University of Nottingham · GBHeart of England NHS Foundation Trust · GBNottingham City Hospital · GBNottingham University Hospitals NHS Trust · GB

Funding

Medical Research Council G0801558Medical Research Council G0801558/1Medical Research Council MR/N005953/1
6 · The paper itself

Abstract

Pseudomonas aeruginosa produces quorum sensing signal molecules that are potential biomarkers for infection.A prospective study of 60 cystic fibrosis patients with chronic P. aeruginosa, who required intravenous antibiotics for pulmonary exacerbations, was undertaken. Clinical measurements and biological samples were obtained at the start and end of the treatment period. Additional data were available for 29 of these patients when they were clinically stable.Cross-sectionally, quorum sensing signal molecules were detectable in the sputum, plasma and urine of 86%, 75% and 83% patients, respectively. They were positively correlated between the three biofluids. Positive correlations were observed for most quorum sensing signal molecules in sputum, plasma and urine, with quantitative measures of pulmonary P. aeruginosa load at the start of a pulmonary exacerbation. Plasma concentrations of 2-nonyl-4-hydroxy-quinoline (NHQ) were significantly higher at the start of a pulmonary exacerbation compared to clinical stability (p<0.01). Following the administration of systemic antibiotics, plasma 2-heptyl-4-hydroxyquinoline (p=0.02) and NHQ concentrations (p<0.01) decreased significantly.In conclusion, quorum sensing signal molecules are detectable in cystic fibrosis patients with pulmonary P. aeruginosa infection and are positively correlated with quantitative measures of P. aeruginosa. NHQ correlates with clinical status and has potential as a novel biomarker for P. aeruginosa infection.

Indexed as

Quorum SensingAdolescentAdultAnti-Bacterial AgentsBiomarkersCross-Sectional StudiesCystic FibrosisFemaleHumansHydroxyquinolinesInfusions, IntravenousMaleMiddle AgedProspective StudiesPseudomonas aeruginosaPseudomonas Infections2-nonyl-4-hydroxyquinolineAnti-Bacterial AgentsBiomarkersHydroxyquinolinesMY 12-62cQuinolines

Identifiers

PMID26022946
PMCPMC4589431
OpenAlexW2161693124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.